Efficacy and safety of a novel vaginal medical device in recurrent bacterial vaginosis: a multicenter clinical trial
{{output}}
Background: The effectiveness of a new vaginal medical device, which contains polycarbophil, 0.04% lauryl glucoside and glycerides (Polybactum®, Effik Italia Spa, Cinisello Balsamo, Milan, Italy), in reducing BV recurrence rate ... ...
